Age-related mitochondrial dysfunction as a key factor in COVID-19 disease

Exp Gerontol. 2020 Dec:142:111147. doi: 10.1016/j.exger.2020.111147. Epub 2020 Nov 7.

Abstract

SARS-CoV-2 causes a severe pneumonia (COVID-19) that affects essentially elderly people. In COVID-19, macrophage infiltration into the lung causes a rapid and intense cytokine storm leading finally to a multi-organ failure and death. Comorbidities such as metabolic syndrome, obesity, type 2 diabetes, lung and cardiovascular diseases, all of them age-associated diseases, increase the severity and lethality of COVID-19. Mitochondrial dysfunction is one of the hallmarks of aging and COVID-19 risk factors. Dysfunctional mitochondria is associated with defective immunological response to viral infections and chronic inflammation. This review discuss how mitochondrial dysfunction is associated with defective immune response in aging and different age-related diseases, and with many of the comorbidities associated with poor prognosis in the progression of COVID-19. We suggest here that chronic inflammation caused by mitochondrial dysfunction is responsible of the explosive release of inflammatory cytokines causing severe pneumonia, multi-organ failure and finally death in COVID-19 patients. Preventive treatments based on therapies improving mitochondrial turnover, dynamics and activity would be essential to protect against COVID-19 severity.

Keywords: COVID-19; Cytokine storm; Inflammaging; Inflammation; Mitochondria; Mitochondrial health; Mitochondrial nutrients; Mitochondrial turnover; SARS-CoV-2.

Publication types

  • Review

MeSH terms

  • Aging / immunology*
  • Animals
  • COVID-19 / complications*
  • COVID-19 / immunology
  • COVID-19 / mortality
  • Cytokine Release Syndrome / etiology
  • Humans
  • Inflammation / immunology
  • Inflammation / physiopathology
  • Mitochondria / physiology*
  • SARS-CoV-2*
  • Ubiquinone / analogs & derivatives
  • Ubiquinone / pharmacology

Substances

  • Ubiquinone
  • coenzyme Q10